142. Matsubara K., Morozumi M., Okada T. et al (2009), “A comparative clinical study of macrolide-sensitive and macrolide- resistant Mycoplasma pneumoniae infections in pediatric patients”, J Infect Chemother 15, pp. 380–383.
143. Matsumoto T., Matsumura K., Anwar K. S. et al (2006), “Prevalence of Chlamydophila pneumoniae among Bangladeshi children under age 5 years with acute respiratory infections”. J Infect Chemother, 12, pp. 139–144.
144. Matsuoka M., Narita M., Okazaki N. et al (2004), “Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan”, Antimico. Agents Chemother 48(12), pp. 4624-4630.
145. Maurice A. (1980), “ Mycoplasma pneumonia”, Infectious Diseases,
W.B. Saunders company, pp. 597 – 600.
146. McDade J. E., Shepard C. C., Fraser D. W., Tsai T. R. et al (1977), “Legionnaires' disease: isolation of a bacterium and demonstration of its role in other respiratory disease”, N. Engl. J. Med. 297, pp. 1197-1203.
147. Megías Montijano A., Gómez Campderá J. A., Navarro Gómez M.
L. et al (2002), “Coinfection with chlamydia and mycoplasma. Incidence in our environment”, An Esp Pediatr. Aug, 57(2), pp.110-5.
148. Michen Z. (2011), “Lobar pneumonia caused by Mycoplasma pneumoniae infection Report of 13 Cases”, Knowledge of infectious diseases, 15 Apr.
Có thể bạn quan tâm!
-
Về Thời Gian Bị Bệnh Và Kháng Sinh Điều Trị Trước Vào Viện -
Phạm Thu Hiền, Đào Minh Tuấn, Nguyễn Phong Lan, Phan Lê Thanh Hương -
Nghiên cứu một số đặc điểm dịch tễ học, lâm sàng viêm phổi không điển hình do vi khuẩn ở trẻ em - 18 -
Nghiên cứu một số đặc điểm dịch tễ học, lâm sàng viêm phổi không điển hình do vi khuẩn ở trẻ em - 20 -
Nghiên cứu một số đặc điểm dịch tễ học, lâm sàng viêm phổi không điển hình do vi khuẩn ở trẻ em - 21 -
Nghiên cứu một số đặc điểm dịch tễ học, lâm sàng viêm phổi không điển hình do vi khuẩn ở trẻ em - 22
Xem toàn bộ 182 trang tài liệu này.
149. Miyashita N. , Sugiu T., Kawai Y., Yamaguchi T., Ouchi K. (2009), “Macrolide – resistant Mycoplasma pneumoniae in patients with comunity- acquired pneumonia in Japan”, COPYRIGHT © by the American College of Chest Physicians.
150. Miyashita N., Kawai Y., Akaike H. et al (2012), “Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia”, BMC Infectious Diseases , 12, pp. 126.
151. Obase Y., Ouchi K. (2007), “Clinical features of severe Mycoplasma pneumoniae pneumonia in adults admitted to an intensive care unit”, Journal of Medical Microbiology, 56, pp. 1625–1629.
152. Molmeret M., Abu - Kwaik Y. (2002), “How does Legionella pneumophila exit the host cell?”, Trends in Microbiology, 10(6), pp. 258–260.
153. Morozumi M., Iwata S., Hasegawa K. (2007), “Increased Macrolide Resistance of Mycoplasma pneumoniae in Pediatric Patients with Community-Acquired Pneumonia”, Antimicrob Agents Chemother, 52(1), pp. 348–350.
154. Muđoz Martínez MJ, de la Fuente Aguado J, González Novoa MC (2006), “Descriptive study of a pneumonia episode due to Legionella”, Rev Clin Esp. Jan; 206(1), pp. 12-6.
155. Nadagir S. D., Bahadur A. K. , Shepur T. A. et al (2011), “Prevalence of Mycoplasma pneumoniae among HIV Infected Children”, Indian J Pediatr, 78(4), pp. 430–434.
156. Narita M. (2007), “Pathogenesis of Neurologic Manifestations of Mycoplasma pneumoniae Infection”, Pediatric Neurology Vol. 41 No. 3, pp.169-166.
157. Newton H. J., Ang D. K., Driel I. R., Hartland E. L. (2010), “Molecular pathogenesis of infections caused by Legionella pneumophila”, Clin Microbiol Rev. Apr, 23(2), pp. 274-98.
158. Ngeow Y. F., Auwanjutha S. et al (2005), “An Asian study on the prevalence of atypical respiratory pathogens in community – acquaired pneumoniae”, International Journal of infectious diseases, (9), pp 144 -153.
159. Nilsson A. C., Björkman P., Welinder-Olsson C. (2009), “Clinical severity of Mycoplasma pneumoniae (MP) infection is associated with bacterial load in oropharyngeal secretions but not with MP genotype”, BMC Infectious Diseases, 10:39.
160. Nocard E., Roux. E. R. (1898), « Le microbe de la peripneumonie »,
Ann, Inst. Pasteur (Paris) 12, pp. 240–262.
161. Normann E. (2003), Chlamydia pneumoniae in children – epidemiology and clinical implications, Acta universitatis upsaliensis Uppsala 2003, comprehensive summaries of uppsala dissertation from the faculty of medicine 1294.
162. Oba Y., Salzman G. (2007), “Chlamydial pneumonias”, Emedicine, February 2007.
163. Oron R., Mor M., Samra Z. et al (2006), “Epidemiological and Clinical Feature of Respiratory Tract Infections Caused by Mycoplasma pneumoniae in a Pediatric Emergency Department”, Israeli Journal of Emergency Medicine,Vol. 6, No. 3 Sept.
164. Paldanius M. (2007), Serologycal studies on Chlamydia pneumoniae infections, Oulun Yliopisto, Oulu.
165. Parker. L. S. (1999), Legionella: risk for infants and children, United States office of Science and Technology, Environmental Protection Office of Water, November 1999.
166. Patel R., Moore M. R., Fields B. S. (2009), “Legionellosis, Bacterial Infections of Humans”, Springer Science Business Media, LLC.
167. Peeling R. W. (1995),“Laboratory diagnosis of Chlamydia pneumoniae infections”, Can J Infect Dis, Jul-Aug; 6(4), pp.
168. Plnar A., Bozdemir N., Kocagöz, T., Alaçam R. (2004), “Rapid detection of bacterial atypical pneumonia agents by multiplex PCR”, Cent Eur J Publ Health 2004; 12 (1), pp. 3-5.
169. Polkowska A., Harjunpää A., Toikkanen S., Lappalainen S. et al (2012), “Increased incidence of Mycoplasma pneumoniae infection in Finland, 2010–2011”, Eurosurveillance, vol 17, weekly isure 5, January 2012.
170. Porath A., Schlaeffer F., Lieberman D. (1997), “The epidemiology of community-acquired pneumonia among hospitalized adults”, J. Infect, 34, pp. 41- 48.
171. Prapphal N., Suwanjutha S., Durongkaveroj P. (2006), “Prevalence and Clinical Presentations of Atypical Pathogens Infection in Community Acquired Pneumonia in Thailand”, J Med Assoc Thai Vol. 89 No. 9.
172. Principi N., Esposito S. (2001), “Emerging role of Mycoplasma pneumoniae and Chlamydia pneumoniae in paediatric respiratory-tract infections”, Lancet Infectious Diseases, 1, pp. 334–44.
173. Principi N., Esposito S., Blasi F., Allegra L. (2001), “Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections”, Clin Infect Dis. May 1;32(9), pp. 1281-9.
174. Puljiz I., Kuzman I., Rode O. D. et al (2006), “Chlamydia pneumoniae and Mycoplasma pneumoniae pneumonia: comparison of clinical, epidemiological characteristics and laboratory profiles”, Epidemiol Infect. June; 134(3), pp. 548–555.
175. Puvan P. S. (1999), “Chlamydia pneumoniae and its link with athrosclerosis”, Engl J Med, Vol 340(2).January 14, pp. 115-126.
176. Radisic M., Torn A., Gutierrez P. et al (2000), “ Severe Acute Lung Injury Caused by Mycoplasma pneumoniae: Potential Role for Steroid Pulses in Treatment”, Clin Infect Dis. 31 (6), pp. 1507-1511.
177. Rastawicki W., Kaluzewski S., Jagielski M., Gierczysk R. (1998), “Epidemiology of Mycoplasma pneumoniae infection in Poland: 28 years of surveillance in Warsaw 1970-1997”, Eurosurveillance, Volume 3, Issue 10, 01 October.
178. Rautonen J., Koskiniemi M., Vaheri A. (1991), “Prognostic factors in childhood acute encephalitis”, Pediatr. Infect. Dis. J. 10, pp. 441- 446.
179. Razin S. (1994), “DNA probes and PCR in diagnosis of mycoplasma
infections”, Mol. Cell. Probes 8, pp. 497-511.
180. Reimann HA (1938), “An acute infection of the respiratory tract with atypical pneumonia: a disease entity probably caused by a filtrable virus”, JAMA,111, pp. 2377-84.
181. Roblin P. M., Dumornay W., Hammerschlag M. R. (1992), “Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae”, J Clin Microbiol, 30, pp. 1968 –1971.
182. Rockey D. D., Lenart J., Stephens R. S. (2000), “Genome sequencing and our understanding of chlamydiae”, Infect Immun, 68, pp. 5473 –5479.
183. Roig J., Rello J. (2003), “Legionnaires’ disease: a rational approach to therapy”, JAC 51, pp.1119 – 1129.
184. Roig J., Sabria M., Castella X. (2007), “Legionnaires’ Disease”,
Infectious Diseases in Critical Care: pp. 404-412.
185. Roig J., Sabria M., Pedro-Botet M. L. (2003), “Legionella spp.: community-acquired and nosocomial infections”, Curr Opin Infect Dis 16, pp. 145 – 151.
186. Rudan I., Boschi-Pinto C., Biloglav Z. (2008), “Epidemiology and etiology of childhood pneumonia”, Bull World Health Organ. 2008 May; 86(5), pp. 408–416.
187. Salaria M., Singh M. (2002), “Atypical Pneumonia in Children”,
Indian Pediatrics 39, pp. 259-266.
188. Samransamruajkit R., Jitchaiwat S., Wachirapaes W. at al (2008), “Prevalence of Mycoplasma and Chlamydia pneumonia in severe community-acquired pneumonia among hospitalized children in Thailand”. Jpn J Infect Dis, 2008 Jan;61(1), pp. 36-9.
189. Sayed Zaki M. E., Goda T. (2009), “ Clinico-pathological study of atypical pathogens in community-acquired pneumonia: a prospective study”, J Infect Developing Countries 2009; 3(3), pp.199-205.
190. Schmidt S. M., Müller C. E., Gürtler L., Bruns R., Ballke E. H. (2005), “Chlamydophila pneumoniae respiratory tract infection aggravates therapy refractory bronchitis or pneumonia in childhood”, Klin Padiatr, Jan-Feb; 217(1), pp. 9-14.
191. Sebastian L. Johnston and Richard J. Martin (2005), “Chlamydophila pneumoniae and Mycoplasma pneumoniae A Role in Asthma Pathogenesis?”, American Journal of Respiratory and Critical Care Medicine Vol 172. pp. 1078-1089.
192. Seo Y. B., Yang T. U., Kim I. S. et al (2012), “Clinical and Epidemiologic Characteristics of Mycoplasma pneumoniae Pneumonia in Adults During 2011 Epidemic”, ct Chemother, Oct;44(5), pp. 367-371.
193. Seto S., Layh-Schmitt G., Kenri T., Miyata M. (2001), “Visualization of the attachment organelle and cytadherence proteins of Mycoplasma pneumoniae by immunofluorescence microscopy”, J. Bacteriol, 183, pp. 1621-1630.
194. Shachor-Meyouhas Y. (2008), “Legionnaires' Disease in Children”,
www.legionella.org.
195. Shunying Z., Yun M., Guifang Z. et al (2003), “Clinical analysis of
11 cases of severe mycoplasma pneumonia”, Chinese Journal of Practical Pediatric, 07.
196. Sidal M., Kilic A., Unuvar E. et al (2007), “Frequency of Chlamydia pneumoniae and Mycoplasma pneumoniae infections in children”, J Trop Pediatr, Aug, 53(4), pp. 225-31.
197. Smeeks F., Savage S. (2006), “Legionnnaires Disease”, eMedicine, Ocr, Concise emergency medicine overview.
198. Storch G., Baine W. B. et al. (1979). “Sporadic community-acquired Legionnaires’ disease in the United States. A case-control study.” Ann Intern Med 90 (4), pp. 596–600.
199. Stout J. E., Yu V. L. (1997), “Legionellosis”, New England Journal of Medicine, 337, pp. 682–687.
200. Suzuki S., Yamazaki T., Narita M. et al (2006), “Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae”, Antimico. Agents Chemother, 50(2), pp. 709-712.
201. Tatlock H. (1944), “A Rickettsia-like organism recovered from guinea pigs”, Proc. Soc. Exp. Biol. Med. 57, pp. 95-99.
202. Tkatch L. S., Kusne S., William D. at al (1998), “Epidemiology of Legionella Pneumonia and Factors Associated with Legionella-Related Mortality at a Tertiary Care Center”, Clinical Infectious Diseases 1998; 27:1479 – 86.
203. Tompkins L. (1996), “Legionella”, Nellson’Textbook of pediatrics,volum 1, chepter 196, pp. 822- 824.
204. Ton C. Y. W., Donnelly C., Harvey G. et al (1999), “ Sillis Multiplex polymerase chain reaction for the simultaneous detection of Mycoplasma pneumoniae, Chlamydia pneumoniae, and Chlamydia psittaci in respiratory samples”, J Clin Pathol, 52, pp. 257–63.
205. Touati A., Pereyre S., Bouziri A., Achour W. et al (2011), “Prevalence of Mycoplasma pneumoniae-associated respiratory tract infections in hospitalized children: results of a 4-year prospective study in Tunis” Diagn Microbiol Infect Dis. Oct, 68(2), pp. 103-9.
206. Tsai M. H., Huang Y. C., Chen C. J. et al (2005), “Chlamydial pneumonia in children requiring hospitalization: effect of mixed infection on clinical outcome”, J Microbiol Immunol Infect. Apr, 38(2), pp.117-22.
207. Uarez M. M., Lorza M. E., Donado J. H. et al (2011), “Clinical and epidemiological characteristics of pediatric patients with positive serology for Mycoplasma pneumoniae, treated in the third level hospital from 2006 to 2008”, Colomb Med. 42, pp.138-43.
208. Uldum S. A., Bangsborg J. M., Gahrn-Hansen B. et al (2012), “Epidemic of Mycoplasma pneumoniae infection in Denmark, 2010 and 2011” , Eurosurveillance, vol 17, weekly isure 5, , January.
209. Vervloet L. A., Camargos P. A. M. (2010), “Clinical, radiographic and hematological characteristic of Mycoplasma pneumoniae pneumonia”, J Pediatr (Rio J), 86(6), pp. 480-487.
210. Vervloet L. A., Marguet C. at al (2007), “Infection by Mycoplasma pneumoniae and its importance as an etiological agent in childhood community – acquired pneumonias”, Braz J infect Dis vol.11 no.5 Salvador oct 2007.
211. Viasus D., Di Yacovo S., Garcia-Vidal C. et al (2013), “Community- acquired Legionella pneumophila pneumonia: a single-center experience with 214 hospitalized sporadic cases over 15 years”, Medicine (Baltimore). Jan, 92(1), pp. 51-60.
212. Waites K. B., Talkington D. F. (2004), “Mycoplasma pneumoniae and Its Role as a Human Pathogen”, Clin Microbiol Rev. October; 17(4), pp. 697–728.
213. Wallace A., Clyde J. (1983), “Mycoplasma pneumoniae respiratory Disease Symposium: Summation and Significance”, The yale journal of biology and medicine, 56, pp. 523-527.
214. Wang K., Gill P., Perera R., Thomson A., Mant D., Harnden A. (2012), “Clinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents with community-acquired pneumonia”, Cochrane Database of Systematic Reviews , Issue 10. Art. No.: CD009175.